Mousa Albeir Y, Abu-Halimah Shadi, Nanjundappa Aravinda, AbuRahma Ali F, Richmond Bryan K
Department of Surgery, Robert C. Byrd Health Sciences Center, West Virginia University, Charleston, WV 25304, USA.
Vasc Endovascular Surg. 2013 Aug;47(6):409-14. doi: 10.1177/1538574413493677.
The evolution of minimally invasive procedures to treat aortic aneurysms has expanded to include access interventions as well. Traditionally, groin exposures have been the standard approach for common femoral artery exposure with open cutdown; however, inherent and related complications to that approach have paved the road to the percutaneous approach. Current available evidence from the literature supports the feasibility and the safety of percutaneous endovascular aneurysm repair (PEVAR); however, predictors of success are not well defined. We should examine all available studies (both prospective and retrospective) in order to draw a conclusion and evidence-based outcome for selecting patients who would benefit the most from PEVAR.
治疗主动脉瘤的微创程序的发展已经扩展到包括通路干预。传统上，腹股沟暴露一直是通过开放切开进行股总动脉暴露的标准方法；然而，该方法固有的及相关并发症为经皮方法铺平了道路。目前文献中的现有证据支持经皮血管腔内动脉瘤修复术（PEVAR）的可行性和安全性；然而，成功的预测因素尚未明确界定。我们应该审查所有可用的研究（前瞻性和回顾性），以便得出结论并获得基于证据的结果，从而选择最能从PEVAR中获益的患者。
